{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:36:56Z","timestamp":1793133416505,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08560-5","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T11:02:42Z","timestamp":1729681362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of heart rate control with ivabradine on hemodynamic in patients with sepsis: study protocol for a prospective, multicenter, randomized controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Jiezhao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deliang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qirui","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2801-8865","authenticated-orcid":false,"given":"Zhenhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"8560_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"8560_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/0885066609340519","volume":"24","author":"MW D\u00fcnser","year":"2009","unstructured":"D\u00fcnser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009;24:293\u2013316. https:\/\/doi.org\/10.1177\/0885066609340519.","journal-title":"J Intensive Care Med"},{"key":"8560_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1139\/Y09-012","volume":"87","author":"K Werdan","year":"2009","unstructured":"Werdan K, Schmidt H, Ebelt H, et al. Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol. 2009;87:266\u201374. https:\/\/doi.org\/10.1139\/Y09-012.","journal-title":"Can J Physiol Pharmacol"},{"key":"8560_CR4","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/1440-1681.12415","volume":"42","author":"H Ebelt","year":"2015","unstructured":"Ebelt H, Gei\u00dfler I, Ruccius S, et al. Direct inhibition, but indirect sensitization of pacemaker activity to sympathetic tone by the interaction of endotoxin with HCN-channels. Clin Exp Pharmacol Physiol. 2015;42:874\u201380. https:\/\/doi.org\/10.1111\/1440-1681.12415.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"8560_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0300-9572(86)90068-7","volume":"14","author":"G Azimi","year":"1986","unstructured":"Azimi G, Vincent JL. Ultimate survival from septic shock. Resuscitation. 1986;14:245\u201353. https:\/\/doi.org\/10.1016\/0300-9572(86)90068-7.","journal-title":"Resuscitation"},{"key":"8560_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00392-011-0375-3","volume":"101","author":"RS Hoke","year":"2012","unstructured":"Hoke RS, M\u00fcller-Werdan U, Lautenschl\u00e4ger C, et al. Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study. Clin Res Cardiol. 2012;101:139\u201347. https:\/\/doi.org\/10.1007\/s00392-011-0375-3.","journal-title":"Clin Res Cardiol"},{"key":"8560_CR7","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/00003246-198710000-00006","volume":"15","author":"MM Parker","year":"1987","unstructured":"Parker MM, Shelhamer JH, Natanson C, et al. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med. 1987;15:923\u20139. https:\/\/doi.org\/10.1097\/00003246-198710000-00006.","journal-title":"Crit Care Med"},{"key":"8560_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yjmcc.2014.05.005","volume":"74","author":"B Rozec","year":"2014","unstructured":"Rozec B. How to slow down septic hearts? J Mol Cell Cardiol. 2014;74:112\u20134. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.05.005.","journal-title":"J Mol Cell Cardiol"},{"key":"8560_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","volume":"8","author":"Y Kakihana","year":"2020","unstructured":"Kakihana Y, Nishida O, Taniguchi T, et al. Efficacy and safety of landiolol, an ultra-short-acting \u03b21-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. Lancet Respir Med. 2020;8:863\u201372. https:\/\/doi.org\/10.1016\/S2213-2600(20)30037-0.","journal-title":"Lancet Respir Med"},{"key":"8560_CR10","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.2013.278477","volume":"310","author":"A Morelli","year":"2013","unstructured":"Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310:1683\u201391. https:\/\/doi.org\/10.1001\/jama.2013.278477.","journal-title":"JAMA"},{"key":"8560_CR11","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1186\/cc6976","volume":"12","author":"CA Schmittinger","year":"2008","unstructured":"Schmittinger CA, D\u00fcnser MW, Haller M, et al. Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression. Crit Care. 2008;12:R99. https:\/\/doi.org\/10.1186\/cc6976.","journal-title":"Crit Care"},{"key":"8560_CR12","doi-asserted-by":"publisher","first-page":"570","DOI":"10.4103\/0970-9185.119154","volume":"29","author":"AS Nair","year":"2013","unstructured":"Nair AS, Gopal TVS. Ivabradine in sepsis. J Anaesthesiol Clin Pharmacol. 2013;29:570\u20131. https:\/\/doi.org\/10.4103\/0970-9185.119154.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"8560_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1085\/jgp.20028593","volume":"120","author":"A Bucchi","year":"2002","unstructured":"Bucchi A, Baruscotti M, DiFrancesco D. Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine. J Gen Physiol. 2002;120:1\u201313. https:\/\/doi.org\/10.1085\/jgp.20028593.","journal-title":"J Gen Physiol"},{"key":"8560_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1476-5381.1994.tb13025.x","volume":"112","author":"C Thollon","year":"1994","unstructured":"Thollon C, Cambarrat C, Vian J, et al. Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol. 1994;112:37\u201342. https:\/\/doi.org\/10.1111\/j.1476-5381.1994.tb13025.x.","journal-title":"Br J Pharmacol"},{"issue":"21","key":"8560_CR15","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1016\/j.jacc.2019.03.478","volume":"73","author":"P van der Meer","year":"2019","unstructured":"van der Meer P, Gaggin HK, Dec GW. ACC\/AHA versus ESC guidelines on heart failure: JACC guideline comparison. J Am Coll Cardiol. 2019;73(21):2756\u201368. https:\/\/doi.org\/10.1016\/j.jacc.2019.03.478.","journal-title":"J Am Coll Cardiol"},{"key":"8560_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/ALN.0000000000001431","volume":"126","author":"ML Miranda","year":"2017","unstructured":"Miranda ML, Balarini MM, Balthazar DS, et al. Ivabradine attenuates the microcirculatory derangements evoked by experimental sepsis. Anesthesiology. 2017;126:140\u20139. https:\/\/doi.org\/10.1097\/ALN.0000000000001431.","journal-title":"Anesthesiology"},{"key":"8560_CR17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00392-011-0323-2","volume":"100","author":"S Nuding","year":"2011","unstructured":"Nuding S, Ebelt H, Hoke RS, et al. Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine: MODI (f)Y trial. Clin Res Cardiol. 2011;100:915\u201323. https:\/\/doi.org\/10.1007\/s00392-011-0323-2.","journal-title":"Clin Res Cardiol"},{"key":"8560_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/0310057X211009913","volume":"49","author":"PK Datta","year":"2021","unstructured":"Datta PK, Rewari V, Ramachandran R, et al. Effectiveness of enteral ivabradine for heart rate control in septic shock: a randomised controlled trial. Anaesth Intensive Care. 2021;49:366\u201378. https:\/\/doi.org\/10.1177\/0310057X211009913.","journal-title":"Anaesth Intensive Care"},{"key":"8560_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346: e7586. https:\/\/doi.org\/10.1136\/bmj.e7586. . Published 2013 Jan 8.","journal-title":"BMJ"},{"key":"8560_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304\u201377. https:\/\/doi.org\/10.1007\/s00134-017-4683-6.","journal-title":"Intensive Care Med"},{"key":"8560_CR21","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1186\/cc6814","volume":"12","author":"A Kumar","year":"2008","unstructured":"Kumar A, Schupp E, Bunnell E, et al. Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock. Crit Care. 2008;12:R35. https:\/\/doi.org\/10.1186\/cc6814.","journal-title":"Crit Care"},{"key":"8560_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.surg.2005.10.010","volume":"139","author":"DC Gore","year":"2006","unstructured":"Gore DC, Wolfe RR. Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis. Surgery. 2006;139:686\u201394. https:\/\/doi.org\/10.1016\/j.surg.2005.10.010.","journal-title":"Surgery"},{"key":"8560_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","volume":"300","author":"JN Matthews","year":"1990","unstructured":"Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ. 1990;300:230\u20135. https:\/\/doi.org\/10.1136\/bmj.300.6719.230.","journal-title":"BMJ"},{"key":"8560_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c869","volume":"340","author":"D Moher","year":"2010","unstructured":"Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340: c869. https:\/\/doi.org\/10.1136\/bmj.c869. . Published 2010 Mar 23.","journal-title":"BMJ."},{"key":"8560_CR25","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.chest.2021.01.009","volume":"159","author":"D Hasegawa","year":"2021","unstructured":"Hasegawa D, Sato R, Prasitlumkum N, et al. Effect of ultrashort-acting \u03b2-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation. Chest. 2021;159:2289\u2013300. https:\/\/doi.org\/10.1016\/j.chest.2021.01.009.","journal-title":"Chest"},{"issue":"11","key":"8560_CR26","doi-asserted-by":"publisher","first-page":"892","DOI":"10.2459\/JCM.0000000000001203","volume":"22","author":"A Martino","year":"2021","unstructured":"Martino A, Rebecchi M, Sette A, et al. Ivabradine versus bisoprolol in the treatment of inappropriate sinus tachycardia: a long-term follow-up study. J Cardiovasc Med (Hagerstown). 2021;22(11):892\u2013900. https:\/\/doi.org\/10.2459\/JCM.0000000000001203.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"8560_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6949320","volume":"2016","author":"I Rohm","year":"2016","unstructured":"Rohm I, Kretzschmar D, Pistulli R, et al. Impact of ivabradine on inflammatory markers in chronic heart failure. J Immunol Res. 2016;2016: 6949320. https:\/\/doi.org\/10.1155\/2016\/6949320.","journal-title":"J Immunol Res"},{"issue":"2","key":"8560_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149694","volume":"11","author":"B Li","year":"2016","unstructured":"Li B, Zhang J, Wang Z, Chen S. Ivabradine prevents low shear stress induced endothelial inflammation and oxidative stress via mTOR\/eNOS pathway. PLoS One. 2016;11(2): e0149694. https:\/\/doi.org\/10.1371\/journal.pone.0149694. Published 2016 Feb 18.","journal-title":"PLoS One."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08560-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08560-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08560-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T11:05:35Z","timestamp":1729681535000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08560-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8560"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08560-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable\u2014no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The informed consent form of participant is attached.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"710"}}